この言語の本文は未訳のため、英語で表示しています。
EndoNet, from Twinanda and colleagues, is a research network that recognizes surgical phases and instruments in laparoscopic cholecystectomy video. It was demonstrated on the public Cholec80 collection. The result is about whether a model can tell where a case is in its sequence. It is not evidence that video analysis reduces complications, and it is not a product cleared to guide a surgeon’s hands.
Recorded laparoscopic cholecystectomy video used for computer-vision research, not a live advisory in the operating room.
The paper reports phase and tool recognition performance on Cholec80. Those research metrics are not restated here as clinical outcomes. Read the paper for the figures.
Twinanda et al., arXiv:1602.03012 · 2016年2月9日 · 年 2016
索引への追加 2026年1月8日
出典を開く教育と市場把握のための条目。医療助言でも推奨でもありません。
手術とロボット
ベンダー報告Robotic systems such as the da Vinci platform can store console time, instrument use, and in some setups video that a surgeon reviews after the case. Vendors present this as coaching and quality review. The surgeon still operates. Nothing in this card says that analytics lower complications. That would be a separate study of a defined program.
da Vinci robotic platform · Post-case reports
画像と放射線
規制IDx-DR, now marketed as LumineticsCore by Digital Diagnostics, was authorized to screen adults with diabetes for more-than-mild diabetic retinopathy without an eye specialist reading the photo first. A primary care team captures images on a specified retinal camera and the software returns a refer-or-rescreen result. It is not a complete eye examination. Pregnancy and several existing retinal conditions sit outside the labeled use.
LumineticsCore (IDx-DR) · Digital Diagnostics · Topcon NW400
画像と放射線
論文The MASAI trial in Sweden randomly assigned screening mammograms to AI-supported reading or standard double reading without AI. Transpara scored each exam and routed lower scores to a single reader and the highest score to double reading, with detection marks available on higher-risk exams. This card quotes the prespecified interim safety analysis, not a claim that every screening program should switch.
Transpara 1.7.0 · ScreenPoint Medical